Sort

Search

01/12/2021 Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome
Verghese, A, Krishnan, D, Chia, YK, Querol, L, Hiew, FL. Optic Nerve Demyelination in IgG4 Anti-Neurofascin 155 Antibody-Positive Combined Central and Peripheral Demyelination Syndrome. Journal Of Central Nervous System Disease. 2021; 13DOI:10.1177/11795735211039913. PMID:34899003. IF:(Q/D).
01/12/2021 Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
Diaz-Manera, J, Kishnani, PS, Kushlaf, H, Ladha, S, Mozaffar, T, Straub, V, Toscano, A, Van der Ploeg, AT, Berger, KI, Clemens, PR, Chien, YH, Day, JW, Illarioshkin, S, Roberts, M, Attarian, S, Borges, JL, Bouhour, F, Choi, YC, Erdem-Ozdamar, S, Goker-Alpan, O, Kostera-Pruszczyk, A, Haack, KA, Hug, C, Huynh-Ba, O, Johnson, J, Thibault, N, Zhou, TY, Dimachkie, MM, Schoser, B. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. LANCET NEUROLOGY. 2021; 20(12)DOI:10.1016/S1474-4422(21)00241-6. PMID:34800399. IF:59.935(Q1/1D).
01/12/2021 Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease
Sampedro, F, Martinez-Horta, S, Perez-Perez, J, Perez-Gonzalez, R, Horta-Barba, A, Campolongo, A, Aracil-Bolanos, I, Gomez-Anson, B, Kulisevsky, J. Interaction between sex and neurofilament light chain on brain structure and clinical severity in Huntington's disease. Annals of Clinical and Translational Neurology. 2021; 8(12)DOI:10.1002/acn3.51460. PMID:34761569. IF:5.430(Q1/3D).
01/12/2021 The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
Aracil-Bolanos, I, Sampedro, F, Pujol, J, Soriano-Mas, C, Gonzalez-de-Echavarri, JM, Kulisevsky, J, Pagonabarraga, J. The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?. HUMAN BRAIN MAPPING. 2021; 42(17)DOI:10.1002/hbm.25650. PMID:34510640. IF:5.399(Q1/3D).
01/12/2021 Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up
Garcia, DS, Rios, LN, Fonticoba, TD, Bartolome, CC, Roca, LG, Painceiras, MF, Miro, CM, Canfield, H, Jesus, S, Aguilar, M, Pastor, P, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JMC, Alonso, PS, Losada, MAG, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LLM, McAfee, D, Martinez-Martin, P, Mir, P. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Diagnostics. 2021; 11(12)DOI:10.3390/diagnostics11122380. PMID:34943619. IF:3.992(Q2/4D).
01/12/2021 Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors
Porta, A, Rodriguez, L, Bai, X, Batalle, G, Roch, G, Pouso-Vazquez, E, Balboni, G, Pol, O. Hydrogen Sulfide Inhibits Inflammatory Pain and Enhances the Analgesic Properties of Delta Opioid Receptors. Antioxidants. 2021; 10(12)DOI:10.3390/antiox10121977. PMID:34943080. IF:7.675(Q1/1D).
01/12/2021 Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach
Vicent-Gil, M, Portella, MJ, Serra-Blasco, M, Navarra-Ventura, G, Crivilles, S, Aguilar, E, Palao, D, Cardoner, N. Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach. PSYCHOLOGICAL MEDICINE. 2021; 51(16)DOI:10.1017/S0033291720001567. PMID:32476636. IF:10.592(Q1/1D).
01/12/2021 Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults
Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Lois, C, Hanseeuw, B, Vilaplana, E, Schultz, AP, Properzi, MJ, Scott, MR, Amariglio, R, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. MOLECULAR PSYCHIATRY. 2021; 26(12)DOI:10.1038/s41380-021-01290-z. PMID:34588623. IF:13.437(Q1/1D).